News
Article
Author(s):
In case you missed it, this week we had news about Pelage's novel PP405 in phase 2a for androgenetic alopecia, the availability of apremilast in the US for pediatric psoriasis, higher patient adherence with pre-filled risankizumab pens, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Health care professionals are recognizing the growing need for advanced technology in modern medical practice.
David Mandell, JD, MBA, stated in the quest to protect against malpractice liability, insurance is certainly the first and most important line of defense.
Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.
Researchers stated the integration of wearable sensors with AI could potentially revolutionize care for patients with atopic dermatitis.
Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.
Researchers assessed patterns of referral from a primary dermatological clinic in Japan.
David Goldberg, MD, JD, stated the use of drugs and devices for conditions that are not otherwise indicated is widespread among physicians and is generally not considered experimental or investigational.
Patients with AD and psoriasis both report diminished levels of happiness compared to the general population.
Latanya Benjamin, MD, FAAD, reviewed a case study of a 35-year-old woman with a 10-year history of vitiligo and concomitant atopic dermatitis
The availability is notable as it introduces the first oral treatment option for young psoriasis patients.
At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.
A review found repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.
Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.
Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.
The study found 95.8% of ocular AEs occurred in AD patients, while SA patients reported only 4.2% of these events.
This week’s collection of the latest dermatologic studies includes the prevalence of vulvar dermatoses among ethnically diverse patients, the adaptation of the Mackie melanoma risk stratification tool into a tablet-based patient questionnaire, siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.
The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.
Anthony Nuara, MD, PhD, reviewed a case study of a 32-year-old professional makeup artist who was concerned about her depigmented patches affecting her livelihood.
In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.
After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.
Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.
A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.
A comprehensive analysis of 71 studies revealed the highest lesion clearance and recurrence rates among individuals who had undergone surgery.
A recent study found prefilled pens with concealed needles showed promise in reducing injection-related anxiety and improving patient adherence.
Acne vulgaris has been reported as an adverse effect of GLP-1 receptor agonists by some patients.